Mai Nishimura

Tsu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Comprehensive Analysis of Type 2 Innate Lymphoid Cell (ILC2) Heterogeneity and Identification of CD81 as a Marker for Pathogenic IL-13+ ILC2s in Atopic Dermatitis Skin.

Comprehensive Analysis of Type 2 Innate Lymphoid Cell (ILC2) Heterogeneity and Identification of CD81 as a Marker for Pathogenic IL-13+ ILC2s in Atopic Dermatitis Skin.

Journal: Allergy

Published: July 07, 2025

Differential Profiles of IL-31- and IL-5/IL-13-Producing Cells Among Helper T Cells, With Subtle IL-31 Expression in Innate Lymphoid Cells.

Differential Profiles of IL-31- and IL-5/IL-13-Producing Cells Among Helper T Cells, With Subtle IL-31 Expression in Innate Lymphoid Cells.

Journal: Experimental dermatology

Published: May 24, 2025

Enhanced Innate Immunity Mediated by IL-36α in Atopic Dermatitis and Differences in Cytokine Profiles of Lymphocytes in the Skin and Draining Lymph Nodes.

Enhanced Innate Immunity Mediated by IL-36α in Atopic Dermatitis and Differences in Cytokine Profiles of Lymphocytes in the Skin and Draining Lymph Nodes.

Journal: Biomolecules

Published: April 19, 2025

Distinct changes in tissue-resident memory T cells following dupilumab treatment in atopic dermatitis.

Distinct changes in tissue-resident memory T cells following dupilumab treatment in atopic dermatitis.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: January 11, 2025

Amelioration of Systemic Amyloidosis by Blocking IL-17A and Not by IL-17F, and Arteriosclerosis by Blocking Both IL-17A and IL-17F in an Inflammatory Skin Mouse Model.

Amelioration of Systemic Amyloidosis by Blocking IL-17A and Not by IL-17F, and Arteriosclerosis by Blocking Both IL-17A and IL-17F in an Inflammatory Skin Mouse Model.

Journal: International journal of molecular sciences

Published: July 13, 2024

A case of Stevens-Johnson syndrome after influenza a virus infection.

A case of Stevens-Johnson syndrome after influenza a virus infection.

Journal: The Journal of dermatology

Published: May 15, 2024

Increased Mortality Risk at Septic Condition in Inflammatory Skin Disorders and the Effect of High-Fat Diet Consumption.

Increased Mortality Risk at Septic Condition in Inflammatory Skin Disorders and the Effect of High-Fat Diet Consumption.

Journal: International journal of molecular sciences

Published: October 26, 2023

A case of anti-MDA5 antibody-positive dermatomyositis with severe necrosis on limbs after COVID-19 vaccination.

A case of anti-MDA5 antibody-positive dermatomyositis with severe necrosis on limbs after COVID-19 vaccination.

Journal: The Journal of dermatology

Published: April 01, 2023

The Interplay of Type 1, Type 2, and Type 3 Lymphocytes and Cytokines in Atopic Dermatitis.

The Interplay of Type 1, Type 2, and Type 3 Lymphocytes and Cytokines in Atopic Dermatitis.

Journal: International journal of molecular sciences

Published: January 11, 2023

Arteriosclerosis Derived from Cutaneous Inflammation Is Ameliorated by the Deletion of IL-17A and IL-17F.

Arteriosclerosis Derived from Cutaneous Inflammation Is Ameliorated by the Deletion of IL-17A and IL-17F.

Journal: International journal of molecular sciences

Published: December 24, 2022

Treatment Strategy for Pyoderma Gangrenosum: Skin Grafting with Immunosuppressive Drugs.

Treatment Strategy for Pyoderma Gangrenosum: Skin Grafting with Immunosuppressive Drugs.

Journal: Journal of clinical medicine

Published: September 24, 2022

Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris.

Successful treatment with cyclosporine and guselkumab for pityriasis rubra pilaris.

Journal: Clinical case reports

Published: May 11, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026